Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Lipella Pharmaceuticals Inc (ID) LIPO

Healthcare Biotechnology
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen... see more

Current News ()

Lipella Pharmaceuticals Announces Positive Final Results from Phase 2a Study of LP-10 in Oral Lichen Planus

GlobeNewswire September 18, 2025

Lipella Pharmaceuticals to Present at Zacks SCR Life Sciences Virtual Investor Forum and Report Final Phase 2a Results in Oral Lichen Planus

PR Newswire September 15, 2025

Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting

GlobeNewswire June 25, 2025

Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market

GlobeNewswire June 20, 2025

Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology

GlobeNewswire June 17, 2025

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

GlobeNewswire June 4, 2025

Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 in Oral Lichen Planus at 2025 AAOM/EAOM International Meeting

GlobeNewswire May 15, 2025

Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on "Global Transformation in Oral Medicine"

GlobeNewswire April 23, 2025

Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025

GlobeNewswire April 22, 2025
View More News ››

Opinion & Analysis ()

No current opinion is available.
View More Opinion ››

Bullboard Posts ()

Buy buddy buy because it's taking off this morning.

And furthermore,you fellas should be  on-board already.
coolfooldumbguy - February 11, 2025

Great stock performance this morning.Wow.

Well guys,this stock is going to be giving shareholders big,or massive profit for me,after the big news came out. So that the early birds...
coolfooldumbguy - February 6, 2025

Buy buddy buy because this stock is going to be

Taking off to the upside today.
coolfooldumbguy - February 6, 2025

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO): Reformulating Ge

http://beyondspx.com/2024/08/02/lipella-pharmaceuticals-inc-nasdaqlipo-reformulating-generic-drugs-for-new-applications/
MikeTester - August 3, 2024

RE:LIPO.....3 mins til opening bell

Live and learn Chasers!!!!!!!!!!!!!!!!!!
Iseneschal - July 31, 2024

LIPO....N.L.O.D...now at $0.9255

How do u like me so far ?????
Iseneschal - July 29, 2024
View more Bullboard ››

TomaGold Corp.

TomaGold Corp.

TomaGold Corporation, together with its subsidiaries, engages in the acquisition, exploration, assessment, and development of ...
View More »